Study Stopped
Synthesis of the chemical precursor for the neuroimaging radiotracer could not be produced in a stable fashion.
Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation
1 other identifier
interventional
17
1 country
1
Brief Summary
The overarching aim of this project is to conduct a randomized controlled study to determine whether Mindfulness-Oriented Recovery Enhancement (MORE) vs. a Support Group (SG) can improve pain regulation and hedonic functions (i.e., natural reward responsiveness) thought to be governed by the endogenous opioid system among opioid-treated, chronic, non-neuropathic back pain patients (CNBP) and thereby improve clinical pain, affect, and opioid use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 11, 2016
CompletedFirst Posted
Study publicly available on registry
October 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedMarch 6, 2020
March 1, 2020
2.7 years
October 11, 2016
March 4, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in endogenous opioid system function in response to pain challenge
PET opioid receptor binding potential from baseline through pain challenge
Change from week 0 to 8 weeks
Changes in fMRI activity level during natural reward processing
Blood oxygen dependent signal (BOLD) response during viewing and regulating response to natural reward cues measured during a fMRI scan.
Change from week 0 to 8 weeks
Secondary Outcomes (3)
Pain sensitivity as a measure of volume of hypertonic saline
Change from week 0 to 8 weeks
Self-report affect ratings
Change from week 0 to 8 weeks
Significant correlation between PET and fMRI measures with improvements in clinical pain, affect, and opioid use
Change from week 0 to 8 weeks
Study Arms (2)
Mindfulness-Oriented Recovery Enhancement
EXPERIMENTALParticipants will attend a Mindfulness-Oriented Recovery Enhancement (MORE) group weekly for eight weeks.
Support Group
ACTIVE COMPARATORParticipants will attend a support group weekly for eight weeks.
Interventions
Mindfulness-Oriented Recovery Enhancement (MORE) is a group behavioral intervention that unites mindfulness training, cognitive reappraisal, and positive psychological principles into an integrative intervention strategy targeting mechanisms of pain and opioid misuse.
A conventional support group will allow participants to express emotions, share experiences, and receive social support under the guidance of a skilled therapist.
Eligibility Criteria
You may qualify if:
- age 21-60 years of age
- English fluency
- /20 vision with corrective lenses
- current chronic, non-neuropathic back pain diagnosis determined by physician assessment
- reporting pain ≥3 on 0-10 scale with opioid medication
- current use of prescription opioids for ≥3 consecutive months
- ability to understand study procedures and to comply with them for the entire length of the study
You may not qualify if:
- Mindfulness experience (e.g., MBSR or shamatha/vipassana meditation)
- psychosis
- untreated, active suicidality in the past month
- and severe non-opioid substance use disorder in the past year as assessed with the MINI
- clinically unstable illness judged to interfere with treatment, and presence of facial/jaw pain
- pregnancy
- inability or unwillingness of individual to give written informed consent
- physical characteristics that preclude neuroimaging or study procedures (e.g., metal implants, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Social Work
Salt Lake City, Utah, 84112, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric L Garland, PhD
The University of Utah
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Director of Integrative Medicine in Supportive Oncology and Survivorship, Huntsman Cancer Institute; Associate Dean for Research and Associate Professor, College of Social Work
Study Record Dates
First Submitted
October 11, 2016
First Posted
October 17, 2016
Study Start
September 1, 2016
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
March 6, 2020
Record last verified: 2020-03